Harold Burstein, MD, PhD, provides an overview of the latest in breast cancer research presented at the 2011 San Antonio Breast Cancer Symposium, including findings...
BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast...
San Antonio Breast Cancer Symposium (SABCS) 2011 preview by Sally Church, PhD of PharmaStrategyBlog.com This video discusses three clinical trials that will be presented at...
EVENT: Update from the Annual San Antonio Breast Cancer Symposium DATE: February 9, 2011 TOPIC: The 33rd Annual San Antonio Breast Cancer Symposium brought scientists...
San Antonio Breast Cancer Symposium 2010 - A discussion with Dr. Sara Hurvitz, Director of Breast Cancer, UCLA Jonsson Comprehensive Cancer Center on the Phase...
The presence of chromosome 17 polysomy effectively predicted which patients would benefit from adjuvant anthracycline chemotherapy. Researchers analyzed 1625 samples from NEAT (National Epirubicin Adjuvant...
Emergency TV Siries GMA 7 Requested San Antonio Emergegency Response Team, Transport Brest Cancer Patient , Malabon To E. Delo santos Hospital QC Last July...
Dr. Behyar Zoghi MD,Ph.D reviews the role of anti-osteoporosis medication in breast cancer treatment (ABCSG-12, ZO-FAST, and AZURE trials presented today on 12/07/2011 at SABCS)...
San Antonio Breast Cancer Symposium 2010 - A discussion with Dr. Alison T. Stopek, (Associate Professor of Medicine, Arizona Cancer Center, University of Arizona Health...
San Antonio Breast Cancer Symposium 2010 - A discussion with Dr. Lesley Fallowfield, Professor of Psycho-oncology at Brighton & Sussex Medical School, University of Sussex,...
